CIK 0001806310
- Non-accelerated filer
- Smaller reporting company
Taysha Gene Therapies, Inc.
Sign in to watch- Ticker
- TSHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843199512
- Phone
- +1 214-612-0000
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Donenberg Phillip B. Director | Grant or award | +21,335 | 241,289 | ||
| 2026-06-01 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +42,671 | 42,671 | ||
| 2025-06-02 | Donenberg Phillip B. Director | Grant or award | +56,623 | 219,954 | ||
| 2025-06-02 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +113,246 | 113,246 | ||
| 2024-05-29 | Donenberg Phillip B. Director | Grant or award | +49,220 | 163,331 | ||
| 2024-05-29 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +98,440 | 98,440 | ||
| 2023-08-16 | Donenberg Phillip B. Director | Purchase | +111,111 | $0.90 | $100K | 114,111 |
| 2023-06-22 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +36,200 | 36,200 | ||
| 2022-06-17 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2022-02-02 | Donenberg Phillip B. Director | Purchase | +3,000 | $7.78 | $23K | 3,000 |
| 2021-06-17 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +15,500 | 15,500 | ||
| 2020-09-23 | Donenberg Phillip B. Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 |
Page 1 of 1 · 12 trades